Bristol-Myers Boosts 2026 Guidance on Portfolio Strength
Bristol-Myers Squibb Co. (NYSE: BMY ) shares are up on Thursday as the company reported its second-quarter financial results for 2026. • Bristol-Myers Squibb stock is showing upward movement. Why are BMY shares climbing? The U.S. large pharma company reported adjusted earnings of $2.04, beating the Wall Street estimate